Formulating and Implementing Pharmaceutical Pricing Policies

1. Pharmaceutical pricing policies: Introduction, key concepts and evidence synthesis<br>2. Analysis of anti-retroviral medicines prices: A review of literature<br>3. Evidence on pharmaceutical pricing policies in Europe<br>4. Pharmaceutical pricing policies in Italy<br>5. Pharmaceutical pricing policies in Indonesia<br>6. Canada&rsquo;s medicine pricing policies: implementation strategies and models<br>7. Pharmaceutical pricing policies in Thailand<br>8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis<br>9. Strategies for medicine pricing in Southeast Asia<br>10. Pharmaceutical pricing policies in Syria<br>11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines<br>12. Integrating Citizens&rsquo; Voices in Pharmaceutical Pricing and Reimbursement<br>13. Pharmaceutical pricing policies in Spain<br>14. Pharmaceutical pricing strategies in the US<br>15. Money matters – How financing for medicines R&D affects medicines, and what to do about it<br>16. The role of Civil Society Organizations ensuring price transparency<br>17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil<br>18. Pharmaceutical pricing policies in Greece